Alzheimer's impacts millions globally, with projections of 100 million affected by 2050 and costs of 800 billion dollars ...

Alzheimer’s disease blood test developer Quanterix put forward new clinical data from its Simoa assay, which it described as ...

La Plata County resident Al Jason, 78, has spent a lifetime caring for others. After his Alzheimer’s disease diagnosis last ...

Alzheimer’s disease erodes memory, independence, and life. A new study finds that Cathepsin B, a protein released by active ...

Alzheimer's disease affects the brain in tragic and seemingly irreversible ways, but a new study gives hope that its ...

Grief is often associated with death, says Paul Rado, 71, of La Plata County. But as he cares for his wife Jackie, 77, who ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...

Scientists at Johns Hopkins Medicine say results of a new National Institutes of Health-funded study are advancing efforts to ...

New guidelines for blood-based biomarkers, the impact of hormone replacement therapy and risks for cognitive decline with red ...

Former Sen. Jon Kyl (R-Ariz.), who served in Congress for more than 25 years, announced Tuesday that he has dementia. Kyl, 83 ...

On Dec. 30, the Caddo Parish Sheriff’s Office (CPSO) asks for the public’s help in finding Kindley Thompson, 81, from Vivian, ...

The FDA accepted Axsome’s supplemental New Drug Application (sNDA) for AXS-05, setting a target action date of April 30, 2026. The priority review designation shortens the FDA’s review timeline from ...